Alessandra Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Sell
12,765
-25
-0.2% -$25.5K 10.84% 1
2026
Q1
$11.8M Sell
12,790
-231
-2% -$234K 10.03% 1
2025
Q4
$14M Buy
+13,021
New +$12.5M 12.44% 1

Other funds holding LLY

Alessandra Capital Management's LLY Position: Q2 2026 in Review

Alessandra Capital Management reduced its Eli Lilly (LLY) stake by 0.2% in Q2 2026, selling an estimated $25.5K and leaving 12,765 shares worth $15.3M. The position accounts for 10.84% of the portfolio, ranked #1.

Alessandra Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alessandra Capital Management held 12,765 shares of Eli Lilly worth $15.3M as of Q2 2026.
  • Alessandra Capital Management sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 10.84% of Alessandra Capital Management's portfolio in Q2 2026, its #1 holding.
  • Alessandra Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alessandra Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.